LUZACNE

LUZACNE is being developed as a PDT option for a highly unmet need in the segment of moderate to severe acne.
As compared to standard acne therapies, LUZACNE aims to achieve:

  • Improvement in efficacy;
  • Better tolerability;
  • Prolonged duration of therapeutic effects;
  • Non-development of microbial resistance;
  • Non-interference in female hormone system;
  • Better patient compliance.

LUZACNE project (Project No. 30218) has benn partially funded by Quadro de Referência Estratégica Nacional (QREN).

Bluepharma
Bluepharma
Bluepharma
Bluepharma
Bluepharma
Bluepharma